| Odds ratio | 95% confidence interval | p value |
---|---|---|---|
Inhaled ciclesonide | 0.2676 | 0.1276–0.5612 | 0.0005 |
Age | 1.0789 | 1.0455–1.1133 | < 0.0001 |
Sex, male | 1.0071 | 0.4899–2.0700 | 0.9847 |
Hypertension | 3.2353 | 1.5251–6.8631 | 0.0022 |
Diabetes | 2.4803 | 1.1914–5.1637 | 0.0152 |
Cardiovascular disease | 2.5287 | 0.8556–7.4738 | 0.0934 |
Heart failure | 32.2222 | 8.2954–125.1619 | < 0.0001 |
Chronic obstructive pulmonary disease | 1.4063 | 0.2947–6.7103 | 0.6689 |
Chronic kidney disease | 11.1074 | 4.3914–28.0950 | < 0.0001 |
Malignancy | 1.6526 | 0.4457–6.1276 | 0.4524 |
Severe COVID-19 infection | 2.3622 | 1.0572–5.2780 | 0.0361 |
High risk Shang’s CSS score | 13.9931 | 4.7086–41.5847 | < 0.0001 |
Systemic corticosteroids | 4.6593 | 1.0810–20.0825 | 0.039 |
Remdesivir | 1.6705 | 0.8112–3.4398 | 0.1638 |
Tocilizumab | 4.5699 | 2.1703–9.6229 | 0.0001 |
Enoxaparin | 1.5534 | 0.7436–3.2454 | 0.2413 |
Traditional Chinese medicine formula NRICM101 | 0.8287 | 0.3424–2.0056 | 0.6769 |